Business Description
TC BioPharm (Holdings) PLC
ISIN : US87807D4007
Share Class Description:
FRA:T0U0: ADRCompare
Compare
Traded in other countries / regions
TCBP.USAT0U0.Germany IPO Date
2022-02-23Description
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.57 | |||||
| Equity-to-Asset | 0.15 | |||||
| Debt-to-Equity | 1.6 | |||||
| Debt-to-EBITDA | 1.94 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 50.5 | |||||
| 3-Year EPS without NRI Growth Rate | 39.5 | |||||
| 3-Year FCF Growth Rate | 33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 77.63 | |||||
| 9-Day RSI | 66.04 | |||||
| 14-Day RSI | 56.96 | |||||
| 6-1 Month Momentum % | -24.31 | |||||
| 12-1 Month Momentum % | -90.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.88 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.21 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -224.9 | |||||
| Shareholder Yield % | 52.14 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -121.98 | |||||
| ROA % | -28.81 | |||||
| ROIC % | -145.08 | |||||
| 3-Year ROIIC % | 198.13 | |||||
| ROC (Joel Greenblatt) % | 19.74 | |||||
| ROCE % | 14.78 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 0.89 | |||||
| PB Ratio | 2.09 | |||||
| Price-to-Tangible-Book | 4.77 | |||||
| EV-to-EBIT | 9.39 | |||||
| EV-to-EBITDA | 5.34 | |||||
| EV-to-Forward-Revenue | 0.01 | |||||
| EV-to-FCF | -0.78 | |||||
| Earnings Yield (Greenblatt) % | 10.65 | |||||
| FCF Yield % | -152.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
TC BioPharm (Holdings) PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | 9.222 | ||
| Beta | 0 | ||
| Volatility % | 109.94 | ||
| 14-Day RSI | 56.96 | ||
| 14-Day ATR (€) | 0.001455 | ||
| 20-Day SMA (€) | 8.25 | ||
| 12-1 Month Momentum % | -90.5 | ||
| 52-Week Range (€) | 6.5 - 110 | ||
| Shares Outstanding (Mil) | 0.57 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
TC BioPharm (Holdings) PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
TC BioPharm (Holdings) PLC Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
TC BioPharm (Holdings) PLC Frequently Asked Questions
What is TC BioPharm (Holdings) PLC(FRA:T0U0)'s stock price today?
The current price of FRA:T0U0 is €8.25. The 52 week high of FRA:T0U0 is €110.00 and 52 week low is €6.50.
When is next earnings date of TC BioPharm (Holdings) PLC(FRA:T0U0)?
The next earnings date of TC BioPharm (Holdings) PLC(FRA:T0U0) is .
Does TC BioPharm (Holdings) PLC(FRA:T0U0) pay dividends? If so, how much?
TC BioPharm (Holdings) PLC(FRA:T0U0) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers